Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Octave Biosciences Takes It Up Another Semitone With Michael J Fox Foundation Grant

Executive Summary

The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.

You may also be interested in...



Leo Grady’s Jona Hopes To Repair Microbiome Testing’s Murky Reputation

After leading Paige to success with the FDA, Grady has turned his attention to the microbiome. He hopes his new company, Jona, will be able to provide detailed insights to doctors, their patients and pharmaceutical players.

OMB Clears Proposed Rule On Lab-Developed Tests

The US FDA appears poised to release long-promised regulations on lab-developed tests. However, some industry observers still have doubts as to whether the agency is truly prepared. 

Execs On The Move: January 2024

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel